The World Health Organisation (WHO) has said it needs "more than a press release" about the Oxford/AstraZeneca vaccine in order to evaluate trial results.
Full ArticleWHO needs 'more than press release' on Oxford vaccine, says immunisations chief
Sky News
0 shares
1 views
Advertisement
Related news coverage
C&F Financial Corporation Announces Record Net Income for 2020
GlobeNewswire
WEST POINT, Va., Jan. 27, 2021 (GLOBE NEWSWIRE) -- C&F Financial Corporation (the Corporation) (NASDAQ:CFFI), the one-bank holding..
-
Vaxart Announces Publication of a Peer-reviewed Journal Article Showing the Potential Clinical and Economic Value of a Norovirus Vaccine
GlobeNewswire
-
Biovaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program
PR Newswire Asia
-
Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients
GlobeNewswire
-
OSE Immunotherapeutics Receives €1.3 Million Milestone Payment from Bpifrance for OSE-127/S95011
GlobeNewswire
You might like
More coverage
Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
GlobeNewswire
Canadian government commits to purchase 52 million doses with option for additional 24 million of Novavax candidate vaccine,..
-
Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Management
GlobeNewswire
-
BJ’s Restaurants, Inc. Provides Business Update and Reports Preliminary Fiscal 2020 Fourth Quarter Results
GlobeNewswire
-
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine
GlobeNewswire
-
Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2
GlobeNewswire